Wondonin, a novel compound, inhibits hypoxia-induced angiogenesis through hypoxia-inducible factor 1 alpha (Q40071435)

17 September 2017

Wondonin, a novel compound, inhibits hypoxia-induced angiogenesis through hypoxia-inducible factor 1 alpha (English)

1 reference

17 September 2017

1 reference

Hyoung-Oh Jun

1

1 reference

17 September 2017

Younghwa Kim

2

1 reference

17 September 2017

Yoo-Wook Kwon

3

1 reference

17 September 2017

Soon-Sun Hong

4

1 reference

17 September 2017

Kyu-Won Kim

5

1 reference

17 September 2017

Jongheon Shin

6

1 reference

17 September 2017

Tae-Yoon Kim

7

1 reference

17 September 2017

language of work or name

English

0 references

publication date

24 September 2007

1 reference

17 September 2017

1 reference

17 September 2017

581

1 reference

17 September 2017

4977-4982

1 reference

17 September 2017

25

1 reference

Tumor angiogenesis: therapeutic implications

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Molecular mechanisms of blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Insulin-like growth factor-II regulates the expression of vascular endothelial growth factor by the human keratinocyte cell line HaCaT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Is HIF-1 alpha a valid therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Long-term culture of capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

[6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Regulation of skin microvasculature angiogenesis, cell migration, and permeability by a specific inhibitor of PKCalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Hypoxia, clonal selection, and the role of HIF-1 in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Transcriptional response to hypoxia in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Chapter 7: MULTISTAGE SKIN CARCINOGENESIS: A USEFUL MODEL FOR THE STUDY OF THE CHEMOPREVENTION OF CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.09.034

10.1016/J.FEBSLET.2007.09.034

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference